Preventing Superbugs and Protecting Patients Act

Summary

Preventing Superbugs and Protecting Patients Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization. The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

6 official files

• Reported to Senate (text)

  Reported to Senate · EN · 5 April 2016

  ViewDownloadOpen at official source

• Reported to Senate (PDF)

  Reported to Senate · EN · 5 April 2016

  ViewDownloadOpen at official source

• Reported to Senate with amendment(s)

  summary · EN · 5 April 2016

  Open at official source

• Introduced in Senate (text)

  Introduced in Senate · EN · 4 February 2016

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 4 February 2016

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 4 February 2016

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.